China Resources Sanjiu Medical & Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Resources Sanjiu Medical & Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Shandong Buchang Pharmaceuticals Co Ltd
sales of 14.26 billion Chinese Renmimbi [US$2.04 billion]
of which 74%
was Pharmaceutical Business),
Beijing Tongrentang Co., Ltd.
(13.27 billion Chinese Renmimbi [US$1.90 billion]
of which 58%
was Retail Operation), and
WuXi AppTec Co Ltd
(12.87 billion Chinese Renmimbi [US$1.85 billion]
of which 50%
was China-based laboratory services).
During the year ended December of 2019, sales at
China Resources Sanjiu Medical & Pharmaceutical Co Ltd were 14.70 billion Chinese Renmimbi (US$2.11 billion).
increase of 9.5%
versus 2018, when the company's sales were 13.43 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at China Resources Sanjiu Medical & Pharmaceutical Co Ltd
(and since 2014, sales have increased a total of 102%).
Sales of Pharmaceutical saw an increase
9.9% in 2019, from
12.93 billion Chinese Renmimbi to 14.21 billion Chinese Renmimbi.
Not all segments of China Resources Sanjiu Medical & Pharmaceutical Co Ltd experienced an increase in sales in 2019:
sales of Packaging and Printing fell 0.7% to 494.97 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).